Form 13-F position report

PHOENIX BIOTECH ACQUISITION

Reported by COWEN AND COMPANY LLC

CEROW CUSIP 71902K113 Manager CIK 0000048966

First reported at 58,905 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q4 2022
Shares 58,905 Quarter-end amount reported
Reported value $2,538 Fair value at quarter end
Consecutive quarters held 1 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 2538
2023-03-31 2322
2023-06-30 3543
2023-09-30 4152
2023-12-31 4702
2024-03-31 43552
2024-06-30 13810
2024-09-30 3759
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for PHOENIX BIOTECH ACQUISITION held by COWEN AND COMPANY LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -737,168 (-100.0%) 0 $0 2025-02-14
Q3 2024 Added 737,168 +50,100 (7.3%) < 0.01% $3,759 2024-11-12
Q2 2024 Added 687,068 +48,467 (7.6%) < 0.01% $13,810 2024-08-07
Q1 2024 Added 638,601 +438,511 (219.2%) < 0.01% $43,552 2024-05-03
Q4 2023 Added 200,090 +142,090 (245.0%) < 0.01% $4,702 2024-02-08
Q3 2023 Unchanged 58,000 0 (0.0%) < 0.01% $4,152 2023-11-09
Q2 2023 Unchanged 58,000 0 (0.0%) < 0.01% $3,543 2023-08-07
Q1 2023 Reduced 58,000 -905 (-1.5%) < 0.01% $2,322 2023-05-09
Q4 2022 New 58,905 +58,905 (0.0%) < 0.01% $2,538 2023-02-09

Who else reported the position

57 managers reported PHOENIX BIOTECH ACQUISITION for Q4 2022.

Managers reporting PHOENIX BIOTECH ACQUISITION in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MANGROVE PARTNERS Unchanged 163,538 0 0.09% $1,679,584 5 qtrs
Radcliffe Capital Management L P Unchanged 150,000 0 0.05% $1,540,545 5 qtrs
Segantii Capital Management Ltd Unchanged 5,000 0 < 0.01% $51,000 5 qtrs
Periscope Capital Inc Added 957,098 +26,300 < 0.01% $40,600 4 qtrs
HIGHBRIDGE CAPITAL MANAGEMENT LLC Reduced 495,194 -177,414 < 0.01% $21,000 5 qtrs
MMCAP International Inc SPC Unchanged 375,000 0 < 0.01% $16,162 5 qtrs
CANTOR FITZGERALD L P Unchanged 363,548 0 < 0.01% $16,000 5 qtrs
Shaolin Capital Management LLC New 374,998 +374,998 < 0.01% $16,000 1 qtr
CLEAR STREET LLC Added 355,185 +16,467 < 0.01% $15,000 5 qtrs
Polar Asset Management Partners Inc Unchanged 300,000 0 < 0.01% $12,930 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 09, 2023
Filing type
13F-HR
Position type
*W EXP 09/01/202

Voting authority reported

Sole
58,905
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.